
Journal of Organic Chemistry p. 2777 - 2782 (1988)
Update date:2022-07-30
Topics:
Doboszewski, B.
Chu, C. K.
Halbeek, H. van
C-Nucleoside analogues of 2',3'-dideoxycytidine, 3'-azido-2',3'-dideoxyuridine (CS-87), and 2',3'-dideoxy-2',3'-didehydrocytidine were synthesized from pseudouridine.The C-nucleoside analogue of 2',3'-dideoxycytidine 4a was prepared by stepwise deoxygenation of 1,3-dimethylpseudouridine (11a) followed by the ring transformation of the uracil to the isocytosine ring.Reduction of the dimethylxanthate 11c to 2',3'-unsaturated derivative 13 followed by the ring transformation reaction afforded the C-nucleoside analogue of 2',3'-dideoxy-2',3'-didehydrocytidine (5).Finally, the C-nucleoside analogue of 3'-azido-2',3'-dideoxyuridine (CS-87, 6) was prepared from 2'-deoxypseudouridine (22a) as the intermediate, in which the 3'-OH was oxidized to a 3'-keto moiety followed by reduction to yield 25a.Mesylation and displacement of the mesyl group of 25a by the azide moiety followed by deblocking of the silyl protecting group yielded the desired compound 6
View MoreAUSHUN PHARMACEUTICAL TECHNOLOGY CO,.LTD
Contact:+86-25-86883560 15951806178
Address:14 Dayingbi, Zhujiang Rd. East, Nanjing, Jiangsu, China.
Chengdu NoVi Biotechnology Co., Ltd.(expird)
Contact:13551243286/028-81458053
Address:NO.168-1-224 JULONG ROAD WUHOU DISTRICT, CHENGDU CITY,SICHUAN PROVINCE
Nanjing Chemipioneer Pharma&Tech Co.,Ltd
website:http://www.chemipioneer.com.cn
Contact:+86-25-52685700
Address:Room 305,A Block,Biological-Medicine Building,Business Start-up Center,Xin-ke 1st Road, High-tech development zone,Nanjing city,Jiangsu Province, China
Beijing Mesochem Technology Co.,LTD
website:http://www.mesochem.com
Contact:0086-10-57862036
Address:2301, Floor 23, Building 9 Lippo Plaza, Yard 8 Ronghua Middle Road, ETDZ, Beijing, China
Shanghai Rainbow Chemistry Co., Ltd.
Contact:+86-21-64968086-5815/5812
Address:3rd floor, Building 7, 251 Faladi Road, Zhangjiang Hi-Tech Park, Pudong District, Shanghai, P.R. China
Doi:10.2298/JSC111104016V
(2012)Doi:10.1039/c2cc16716f
(2012)Doi:10.1016/j.bmc.2009.01.040
(2009)Doi:10.1007/BF00953428
(1988)Doi:10.1016/j.tet.2009.01.087
(2009)Doi:10.1016/S0022-328X(98)00571-3
(1998)